Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Xiaojian Sun
Introduction
Xiaojian Sun is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of medical diagnostics. His work focuses on developing methods that enhance the understanding of tumor responses to treatments, particularly in the context of cancer therapy.
Latest Patents
One of Xiaojian Sun's key patents is titled "Tivozanib response prediction." This patent discloses a diagnostic method for predicting whether a human tumor will be sensitive or resistant to treatment with tivozanib (AV-951). The method is based on the measurement of macrophage content in a tissue sample from a tumor. This measurement can be conducted through the analysis of macrophage marker gene expression, utilizing techniques such as RNA analysis or immunohistochemistry. Xiaojian Sun holds 1 patent related to this innovative diagnostic approach.
Career Highlights
Xiaojian Sun is currently associated with Aveo Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Aveo Pharmaceuticals focuses on improving cancer treatment outcomes through innovative diagnostic methods.
Collaborations
Xiaojian Sun has collaborated with notable colleagues, including Jie Lin and Bin Feng, who contribute to the research and development initiatives within the company.
Conclusion
Xiaojian Sun's contributions to the field of cancer diagnostics exemplify the importance of innovation in medical research. His work not only enhances the understanding of tumor behavior but also paves the way for more effective treatment strategies.